Pirfenidone

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Pirfenidone and local guidelines before prescribing.

Antifibrotic

Mechanism

Antifibrotic with anti-inflammatory action.

Uses

Idiopathic pulmonary fibrosis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Nausea, photosensitivity rash, raised LFT, dyspepsia, fatigue.

Interactions

Strong CYP1A2 inhibitors (fluvoxamine, ciprofloxacin) raise levels; smoking reduces levels.

Contraindications and cautions

Severe renal or hepatic impairment

Monitoring

LFT, weight

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Avoid in severe renal or hepatic impairment

Overdose and reversal

Supportive

Special advice

Take with food; sun protection; LFT monthly for first 6 months.

More from the textbook: uses, cautions and other points
Where it is discussed in the book